Inventiva (IVA) Exchange Rate Effect (2021 - 2022)
Inventiva's (IVA) quarterly Exchange Rate Effect came in at $2.4 million in Q4 2022, down 28.16% year-on-year from $3.4 million in Q4 2021, and up 171.16% quarter-over-quarter from -$3.4 million in Q3 2022.
Inventiva (IVA) Exchange Rate Effect (2021 - 2022) Analysis & Trends
Inventiva's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2022.
- On a quarterly basis, Exchange Rate Effect fell 28.16% year-over-year to $2.4 million in Q4 2022; TTM through Dec 2022 was $10.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$544772.4, down 141.21% from the prior year.
- Exchange Rate Effect grew to $2.4 million in Q4 2022 per IVA's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $8.0 million in Q2 2021 and bottomed at -$4.4 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.44 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 22, 2022 | -3.43 Mn |
| Sep 22, 2022 | -3.43 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Jun 30, 2021 | 7.99 Mn |
| Jun 30, 2021 | 7.99 Mn |
| Mar 31, 2021 | -4.42 Mn |
| Mar 31, 2021 | -4.42 Mn |